Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1957 Nov 2;2(5052):1028–1032. doi: 10.1136/bmj.2.5052.1028

The Clinical Applications of Triiodothyronine

A W G Goolden, Craig D Burrell
PMCID: PMC1962693  PMID: 13472038

Full text

PDF
1028

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBRIGHT E. C., LARSON F. C., TUST R. H. In vitro conversion of thyroxin to triiodothyronine by kidney slices. Proc Soc Exp Biol Med. 1954 May;86(1):137–140. doi: 10.3181/00379727-86-21031. [DOI] [PubMed] [Google Scholar]
  2. ANDERSON B. G. Potency and duration of action of triiodothyronine and thyroxine in rats and mice. Endocrinology. 1954 Jun;54(6):659–665. doi: 10.1210/endo-54-6-659. [DOI] [PubMed] [Google Scholar]
  3. ASPER S. P., Jr, SELENKOW H. A., PLAMONDON C. A. A comparison of the metabolic activities of 3,5,3-L-triiodothyronine and L-thyroxine in myxedema. Bull Johns Hopkins Hosp. 1953 Sep;93(3):164–198. [PubMed] [Google Scholar]
  4. BENUA R. S., DOBYNS B. M., NINMER A. Triiodothyronine in the serum of patients treated with radioactive iodine. J Clin Endocrinol Metab. 1955 Nov;15(11):1367–1378. doi: 10.1210/jcem-15-11-1367. [DOI] [PubMed] [Google Scholar]
  5. BLACKBURN C. M., McCONAHEY W. M., KEATING F. R., Jr, ALBERT A. Calorigenic effects of single intravenous doses of L-triiodothyronine and L-thyroxine in myxedematous persons. J Clin Invest. 1954 Jun;33(6):819–824. doi: 10.1172/JCI102953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. BROWN-GRANT K. A comparison of thyroxine and triiodothyronine as inhibitors of pituitary thyrothrophic hormone secretion in the rabbit. J Physiol. 1955 Feb 28;127(2):352–357. doi: 10.1113/jphysiol.1955.sp005262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. COLVILLE K. I., BONNYCASTLE D. D. Potency of triiodothyronine. Lancet. 1953 Jul 4;265(6775):44–45. doi: 10.1016/s0140-6736(53)90041-5. [DOI] [PubMed] [Google Scholar]
  8. DEISS W. P., ALBRIGHT E. C., LARSON F. C. A study of the nature of the circulating thyroid hormone in euthyroid and hyperthyroid subjects by use of paper electrophoresis. J Clin Invest. 1952 Nov;31(11):1000–1005. doi: 10.1172/JCI102683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DELTOUR G., KARAMOURTZOUNIS J. Action comparée de la L-3,5,3'-triiodothyronine et de la L-thyroxine sur la consommation d'oxygène du rat thyroidectomise. Ann Endocrinol (Paris) 1953;14(1):82–86. [PubMed] [Google Scholar]
  10. DYSON A., WOOD M. W. Triiodothyronine in myxoedema coma. Lancet. 1956 Oct 13;271(6946):757–759. doi: 10.1016/s0140-6736(56)90963-1. [DOI] [PubMed] [Google Scholar]
  11. FLOCK E. V., BOLLMAN J. L. The metabolism of thyroxine and triiodothyronine in the eviscerated rat. J Biol Chem. 1955 Jun;214(2):709–721. [PubMed] [Google Scholar]
  12. FRASER R., HOBSON Q. J. G., ARNOTT D. G., EMERY E. W. The urinary excretion of radioiodine as a clinical test of thyroid function. Q J Med. 1953 Jan;22(85):99–120. [PubMed] [Google Scholar]
  13. FRAWLEY T. F., MCCLINTOCK J. C., BEEBE R. T., MARTHY G. L. Metabolic and therapeutic effects of triiodothyronine. J Am Med Assoc. 1956 Feb 25;160(8):646–652. doi: 10.1001/jama.1956.02960430036007. [DOI] [PubMed] [Google Scholar]
  14. GEMMIL C. L. Comparison of activity of thyroxine and 3, 5, 3'-triiodothyronine. Am J Physiol. 1953 Feb;172(2):286–290. doi: 10.1152/ajplegacy.1953.172.2.286. [DOI] [PubMed] [Google Scholar]
  15. GROSS J., PITT-RIVERS R. Physiological activity of 3:5:3'-L-triiodothyronine. Lancet. 1952 Mar 22;1(6708):593–594. doi: 10.1016/s0140-6736(52)90104-9. [DOI] [PubMed] [Google Scholar]
  16. GROSS J., PITT-RIVERS R., TROTTER W. R. Effect of 3:5:3'-L-triiodothyronine in myxoedema. Lancet. 1952 May 24;1(6717):1044–1045. doi: 10.1016/s0140-6736(52)90695-8. [DOI] [PubMed] [Google Scholar]
  17. HEMING A. E., HOLTKAMP D. E. Calorigenic and antigoitrogenic actions of L-triiodothyronine and L-thyroxine in thyroidectomized and intact rats. Proc Soc Exp Biol Med. 1953 Aug-Sep;83(4):875–879. doi: 10.3181/00379727-83-20520. [DOI] [PubMed] [Google Scholar]
  18. HILTON G. The role of radioiodine in the treatment of carcinoma of the thyroid; Mackenzie Davidson memorial lecture. Br J Radiol. 1956 Jun;29(342):297–310. doi: 10.1259/0007-1285-29-342-297. [DOI] [PubMed] [Google Scholar]
  19. Harington C. R., Barger G. Chemistry of Thyroxine: Constitution and Synthesis of Thyroxine. Biochem J. 1927;21(1):169–183. doi: 10.1042/bj0210169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Harington C. R. Chemistry of Thyroxine: Constitution and Synthesis of Desiodo-Thyroxine. Biochem J. 1926;20(2):300–313. doi: 10.1042/bj0200300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. KALANT H., LEE R., SELLERS E. A. Metabolic fate of radioactive thyroid hormones in normal and propylthiouracil-treated rats. Endocrinology. 1955 Feb;56(2):127–134. doi: 10.1210/endo-56-2-127. [DOI] [PubMed] [Google Scholar]
  22. KARHAUSEN L., ZYLBERSZAC S. Myxoedema coma in a patient with Hashimoto's struma. Br Med J. 1955 Sep 24;2(4942):766–768. doi: 10.1136/bmj.2.4942.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. KURLAND G. S., HAMOLSKY M. W., FREEDBERG A. S. Studies in non-myxedematous hypometabolism. I. The clinical syndrome and the effects of thiiodothyronine, alone or combined with thyroxine. J Clin Endocrinol Metab. 1955 Nov;15(11):1354–1360. doi: 10.1210/jcem-15-11-1354. [DOI] [PubMed] [Google Scholar]
  24. LARSON F. C., TOMITA K., ALBRIGHT E. C. The deiodination of thyroxine to triiodothyronine by kidney slices of rats with varying thyroid function. Endocrinology. 1955 Sep;57(3):338–344. doi: 10.1210/endo-57-3-338. [DOI] [PubMed] [Google Scholar]
  25. LE MARQUAND H. S., HAUSMANN W., HEMSTED E. H. Myxoedema as a cause of death; report of two cases. Br Med J. 1953 Mar 28;1(4812):704–706. doi: 10.1136/bmj.1.4812.704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. LERMAN J. The physiologic activity of l-triiodothyronine. J Clin Endocrinol Metab. 1953 Nov;13(11):1341–1346. doi: 10.1210/jcem-13-11-1341. [DOI] [PubMed] [Google Scholar]
  27. MACLAGAN N. F., SPROTT W. E. The in-vitro deiodination of thyroxine and triiodothyronine. Lancet. 1954 Aug 21;267(6834):368–369. [PubMed] [Google Scholar]
  28. MALDEN M. Hypothermic coma in myxoedema. Br Med J. 1955 Sep 24;2(4942):764–766. doi: 10.1136/bmj.2.4942.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. MARSHALL R. J., MCCAUGHEY W. T. Hypothermic myxoedema coma with muscle damage and acute renal tubular necrosis. Lancet. 1956 Oct 13;271(6946):754–757. doi: 10.1016/s0140-6736(56)90962-x. [DOI] [PubMed] [Google Scholar]
  30. PERLMUTTER M., SLATER S. Use of thyroid hormone to differentiate between hyperthyroidism and euthyroidism. J Am Med Assoc. 1955 Jul 2;158(9):718–720. doi: 10.1001/jama.1955.02960090012003. [DOI] [PubMed] [Google Scholar]
  31. PITT-RIVERS R., STANBURY J. B., RAPP B. Conversion of thyroxine to 3-5-3'-triiodothyronine in vivo. J Clin Endocrinol Metab. 1955 May;15(5):616–620. doi: 10.1210/jcem-15-5-616. [DOI] [PubMed] [Google Scholar]
  33. Pitt-Rivers R. The oxidation of diiodotyrosine derivatives. Biochem J. 1948;43(2):223–231. doi: 10.1042/bj0430223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. ROBBINS J., RALL J. E. Zone electrophoresis in filter paper of serum I 131 after radioiodide administration. Proc Soc Exp Biol Med. 1952 Nov;81(2):530–536. doi: 10.3181/00379727-81-19930. [DOI] [PubMed] [Google Scholar]
  35. ROCHE J., LISSITZKY S., MICHEL R. Sur la triiodothyronine, produit intermédiaire de la transformation de la diiodothyronine en thyroxine. C R Hebd Seances Acad Sci. 1952 Feb 25;234(9):997–998. [PubMed] [Google Scholar]
  36. ROCHE J., MICHEL R., TATA J. Sur l'origine de la triiodothyronine plasmatique. C R Seances Soc Biol Fil. 1954 Jun;148(11-12):968–971. [PubMed] [Google Scholar]
  37. SELENKOW H. A., ASPER S. P., Jr The effectiveness of triiodothyronine or thyroxine administered orally in the treatment of myxedema. J Clin Endocrinol Metab. 1955 Mar;15(3):285–296. doi: 10.1210/jcem-15-3-285. [DOI] [PubMed] [Google Scholar]
  38. STARR P., LIEBHOLD-SCHUECK R. Effect of oral thyroxine and tri-iodo-thyronine on radioactive iodine uptake and serum protein bound iodine in normal human subjects. Proc Soc Exp Biol Med. 1953 May;83(1):52–54. doi: 10.3181/00379727-83-20262. [DOI] [PubMed] [Google Scholar]
  39. SUMMERS V. K. Myxoedema coma. Br Med J. 1953 Aug 15;2(4832):366–368. doi: 10.1136/bmj.2.4832.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. TITTLE C. R. Effects of 3,5,3' l-triiodothyronine in patients with metabolic insufficiency; preliminary report. J Am Med Assoc. 1956 Sep 22;162(4):271–274. doi: 10.1001/jama.1956.02970210011005. [DOI] [PubMed] [Google Scholar]
  41. TOMICH E. G., WOOLLETT E. A. The biological activity of triiodothyronine. Lancet. 1953 Apr 11;1(6763):726–726. doi: 10.1016/s0140-6736(53)91850-9. [DOI] [PubMed] [Google Scholar]
  42. WERNER S. C., SPOONER M. A new and simple test for hyperthyroidism employing L-triiodothyronine and the twenty-four hour I-131 uptake method. Bull N Y Acad Med. 1955 Feb;31(2):137–145. [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES